FY2027 EPS Estimates for HCA Healthcare Increased by Analyst

HCA Healthcare, Inc. (NYSE:HCA) – Leerink Partnrs boosted their FY2027 earnings per share (EPS) estimates for HCA Healthcare in a report released on Monday, January 27th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $32.55 per share for the year, up from their previous forecast of $30.68. The consensus estimate for HCA Healthcare’s current full-year earnings is $21.75 per share.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same quarter last year, the company posted $5.90 EPS.

HCA has been the topic of several other research reports. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the company from $400.00 to $320.00 in a report on Monday, November 25th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Oppenheimer raised their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $382.19.

HCA Healthcare Trading Down 0.3 %

Shares of HCA stock opened at $327.80 on Wednesday. HCA Healthcare has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a 50-day moving average price of $313.28 and a 200 day moving average price of $353.27. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market capitalization of $83.03 billion, a price-to-earnings ratio of 14.72, a PEG ratio of 1.09 and a beta of 1.64.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $39,000. Activest Wealth Management lifted its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares during the period. Canoe Financial LP acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $41,000. Capital Performance Advisors LLP acquired a new stake in HCA Healthcare during the 3rd quarter worth $41,000. Finally, Northwest Investment Counselors LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth $44,000. 62.73% of the stock is currently owned by institutional investors.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.88%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.